SCHEMBL6370988

SCHEMBL6370988

NC[CH]C(CN)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19995789 0.65
SCHEMBL15388798 0.61
SCHEMBL354646 0.61
SCHEMBL7915757 0.61
SCHEMBL24178808 0.59
Hydrochloric Acid SCHEMBL579057 0.59
SCHEMBL9440433 0.59
Hydrochloric Acid SCHEMBL9308558 0.59
SCHEMBL63866 0.52
SCHEMBL8361968 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897209-B2 Labelled factor XIIIa substrates GE HEALTHCARE LIMITED (GB) 2005-05-24 US disclosed
EP-0994730-B1 LABELLED FACTOR XIIIa SUBSTRATES AMERSHAM PLC (GB) 2005-05-04 EP disclosed
US-20040076580-A1 Labelled factor XIIIa substrates AMERSHAM PLC (GB) 2004-04-22 US disclosed
US-6653299-B1 Radiotagged complexes; thrombosis, embolism, atherosclerosis, inflammation, cancer NYCOMED AMERSHAM PLC (GB) 2003-11-25 US disclosed